These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22487944)

  • 1. Intrapleural agents for pleural infection: fibrinolytics and beyond.
    Rahman NM
    Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
    Muhammad Redzwan SRA
    Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
    Rahman NM; Maskell NA; West A; Teoh R; Arnold A; Mackinlay C; Peckham D; Davies CW; Ali N; Kinnear W; Bentley A; Kahan BC; Wrightson JM; Davies HE; Hooper CE; Lee YC; Hedley EL; Crosthwaite N; Choo L; Helm EJ; Gleeson FV; Nunn AJ; Davies RJ
    N Engl J Med; 2011 Aug; 365(6):518-26. PubMed ID: 21830966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies to manage complicated pleural effusions.
    Safiyeh M; Huang D
    Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
    Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
    Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
    Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
    Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
    Levinson GM; Pennington DW
    Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
    Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
    J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.K. Controlled trial of intrapleural streptokinase for pleural infection.
    Maskell NA; Davies CW; Nunn AJ; Hedley EL; Gleeson FV; Miller R; Gabe R; Rees GL; Peto TE; Woodhead MA; Lane DJ; Darbyshire JH; Davies RJ;
    N Engl J Med; 2005 Mar; 352(9):865-74. PubMed ID: 15745977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of parapneumonic effusions and empyema.
    Psallidas I; Corcoran JP; Rahman NM
    Semin Respir Crit Care Med; 2014 Dec; 35(6):715-22. PubMed ID: 25463162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis.
    Chong WH; Hu K; Saha BK; Chopra A
    Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of fibrinolytics and deoxyribonuclease in patients with pleural infection].
    Zhao ZW; Shi HZ
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2343-2345. PubMed ID: 34404122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.